Literature DB >> 32262965

3D-printed bioceramic scaffolds with a Fe3O4/graphene oxide nanocomposite interface for hyperthermia therapy of bone tumor cells.

Yongliang Zhang1, Dong Zhai, Mengchi Xu, Qingqiang Yao, Jiang Chang, Chengtie Wu.   

Abstract

Simultaneous therapy and regeneration of bone tumor-induced defects still remain to be a significant challenge. Conventional therapy strategy by implanting bone graft materials can regenerate the bone defects after surgery but cannot kill residual tumor cells. In this study, we successfully prepared a 3D-printed β-tricalcium phosphate bioceramic scaffold with surface modification of Fe3O4 nanoparticles/graphene oxide nanocomposite layers (named β-TCP-Fe-GO). The prepared β-TCP-Fe-GO scaffolds possess a highly ordered macroporous structure with triangle pore morphology and a pore size of around 300-500 μm. The struts of β-TCP-Fe-GO scaffolds were uniformly deposited with Fe3O4/GO sandwich-like composite layers in which nano-sized Fe3O4 particles were wrapped by GO sheets. The Fe3O4 content in the β-TCP-Fe-GO scaffolds can be effectively modulated by controlling the coating times; the final content of Fe3O4 in β-TCP-8Fe-GO scaffolds is no more than 1% after coating 8 times. Such low content of Fe3O4 in the scaffolds endows them with super paramagnetic behavior and hyperthermal effects. The temperature of the scaffolds can be modulated in the range 50-80 °C under an alternating magnetic field for 15 minutes by controlling the magnetic intensity and Fe3O4 content. The excellent hyperthermal effect of β-TCP-Fe-GO scaffolds induced more than 75% cell death for osteosarcoma cells (MG-63) in vitro. Furthermore, the β-TCP-Fe-GO scaffolds significantly enhanced alkaline phosphatase (ALP) activity and osteogenic gene expression, such as OPN, Runx2, OCN and BSP, of rabbit bone marrow stromal cells (rBMSCs) and significantly stimulated rBMSCs proliferation as compared to pure β-TCP scaffolds by the synergistic effect of GO and the released Fe ions. Therefore, the prepared β-TCP-Fe-GO scaffolds possess prominent magnetothermal ability and excellent bone-forming activity. This study is believed to pave the way for the design and fabrication of novel tissue engineering scaffolds in a combination of therapy and regeneration functions.

Entities:  

Year:  2016        PMID: 32262965     DOI: 10.1039/c6tb00390g

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  6 in total

Review 1.  Emerging zero-dimensional to four-dimensional biomaterials for bone regeneration.

Authors:  Haoyu Fang; Daoyu Zhu; Qianhao Yang; Yixuan Chen; Changqing Zhang; Junjie Gao; Youshui Gao
Journal:  J Nanobiotechnology       Date:  2022-01-06       Impact factor: 10.435

2.  Osteogenic and anti-tumor Cu and Mn-doped borosilicate nanoparticles for syncretic bone repair and chemodynamic therapy in bone tumor treatment.

Authors:  Libin Pang; Renliang Zhao; Jing Chen; Jingxin Ding; Xiaochen Chen; Wenwen Chai; Xu Cui; Xiaolin Li; Deping Wang; Haobo Pan
Journal:  Bioact Mater       Date:  2021-10-25

Review 3.  The Development Tendency of 3D-Printed Bioceramic Scaffolds for Applications Ranging From Bone Tissue Regeneration to Bone Tumor Therapy.

Authors:  Zhixiang Fang; Jihang Chen; Jiangxia Pan; Guoqiang Liu; Chen Zhao
Journal:  Front Bioeng Biotechnol       Date:  2021-12-20

Review 4.  Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma.

Authors:  Kunzhe Wu; Beibei Yu; Di Li; Yangyang Tian; Yan Liu; Jinlan Jiang
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

5.  Combined Photothermal and Photodynamic Therapy for Cancer Treatment Using a Multifunctional Graphene Oxide.

Authors:  Shi Guo; Zhengmei Song; Ding-Kun Ji; Giacomo Reina; Jean-Daniel Fauny; Yuta Nishina; Cécilia Ménard-Moyon; Alberto Bianco
Journal:  Pharmaceutics       Date:  2022-06-28       Impact factor: 6.525

Review 6.  Therapeutic response differences between 2D and 3D tumor models of magnetic hyperthermia.

Authors:  Ruby Gupta; Deepika Sharma
Journal:  Nanoscale Adv       Date:  2021-05-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.